Literature DB >> 2991915

Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene.

I H Gelman, S Silverstein.   

Abstract

A HeLa cell transient-expression assay system was used to determine if isolated immediate early (alpha) genes from herpes simplex virus (HSV) could transcriptionally activate (transactivate) the type 1 (HSV-1) thymidine kinase (TK) gene [an early (beta) gene]. Cells transfected with the TK gene alone transcribed very low levels of TK RNA. Cells cotransfected with plasmids bearing the sequences that encode the alpha-gene product infected cell protein 0 or 4 (ICP0 or ICP4) and the TK gene faithfully transcribed high levels of TK RNA. The plasmid containing the sequences encoding ICP0 was a more potent transactivator than the plasmid containing the sequences for ICP4.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991915      PMCID: PMC390548          DOI: 10.1073/pnas.82.16.5265

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Characterization of transcription-deficient temperature-sensitive mutants of herpes simplex virus type 1.

Authors:  R J Watson; J B Clements
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

2.  Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides.

Authors:  R W Honess; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Intertypic complementation and recombination between temperature-sensitive mutants of herpes simplex virus types 1 and 2.

Authors:  J Esparza; B Benyesh-Melnick; P A Schaffer
Journal:  Virology       Date:  1976-04       Impact factor: 3.616

4.  Degradation of cellular mRNA during infection by herpes simplex virus.

Authors:  Y Nishioka; S Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

5.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

6.  Regulation of herpes simplex virus-induced thymidine kinase.

Authors:  B Garfinkle; B R McAuslan
Journal:  Biochem Biophys Res Commun       Date:  1974-06-04       Impact factor: 3.575

7.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

8.  Positive control of the herpes simplex virus thymidine kinase gene requires upstream DNA sequences.

Authors:  J R Smiley; H Swan; M M Pater; A Pater; M E Halpern
Journal:  J Virol       Date:  1983-08       Impact factor: 5.103

9.  Evidence that herpes simplex virus DNA is transcribed by cellular RNA polymerase B.

Authors:  F Costanzo; G Campadelli-Fiume; L Foa-Tomasi; E Cassai
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

10.  Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus.

Authors:  J M Leiden; R Buttyan; P G Spear
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

View more
  185 in total

1.  Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

Authors:  W E Hobbs; N A DeLuca
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways.

Authors:  T M Soliman; S J Silverstein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.

Authors:  W E Hobbs; D E Brough; I Kovesdi; N A DeLuca
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression.

Authors:  Dool-Bboon Kim; Susan Zabierowski; Neal A DeLuca
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0.

Authors:  K L Mossman; J R Smiley
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule.

Authors:  M A Hardwicke; P J Vaughan; R E Sekulovich; R O'Conner; R M Sandri-Goldin
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation.

Authors:  Heba H Mostafa; Thornton W Thompson; Anna S Kushnir; Steve D Haenchen; Adam M Bayless; Joshua G Hilliard; Malen A Link; Lisa A Pitcher; Emma Loveday; Priscilla A Schaffer; David J Davido
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

8.  Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA.

Authors:  B Grondin; N DeLuca
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA.

Authors:  W Z Cai; P A Schaffer
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.

Authors:  C R Brown; M S Nakamura; J D Mosca; G S Hayward; S E Straus; L P Perera
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.